Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons

Dual antiplatelet therapy simultaneously blocks different platelet activation pathways and might thus be more potent at inhibiting platelet activation and more effective at reducing major ischemic vascular events compared to antiplatelet monotherapy. Aspirin plus clopidogrel dual therapy is now the...

Descripción completa

Detalles Bibliográficos
Autor principal: Hong, Keun-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101094/
https://www.ncbi.nlm.nih.gov/pubmed/25045370
http://dx.doi.org/10.3988/jcn.2014.10.3.189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101094/
https://www.ncbi.nlm.nih.gov/pubmed/25045370
http://dx.doi.org/10.3988/jcn.2014.10.3.189

Ejemplares similares